Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2009 Apr 15;19(8):2125-8. doi: 10.1016/j.bmcl.2009.03.010. Epub 2009 Mar 9.

Discovery of potent and selective DP1 receptor antagonists in the azaindole series.

Author information

1
Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Quebec, Canada. yves_leblanc@merck.com

Abstract

Azaindole based structures were evaluated as DP1 receptor antagonists. This work has lead to the discovery of potent, selective and distinct DP1 receptor antagonists.

PMID:
19307115
DOI:
10.1016/j.bmcl.2009.03.010
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center